Literature DB >> 1359373

A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs.

D J Vandenbergh1, A M Persico, G R Uhl.   

Abstract

We describe a cDNA for the human dopamine transporter, which has been implicated in several human disorders linked to dopaminergic function. The cDNA predicts reduced glycosylation of the protein with respect to the rat transporter, as well as a novel repetitive element in the 3' untranslated region of the cDNA. A TaqI RFLP is also reported that shows a race-specific difference in allelic frequencies.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1359373     DOI： 10.1016/0169-328x(92)90165-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN： 0169-328X


  39 in total

1.  Additive effects of the dopamine D2 receptor and dopamine transporter genes on the error-related negativity in young children.

Authors:  A Meyer; D N Klein; D C Torpey; A J Kujawa; E P Hayden; H I Sheikh; S M Singh; G Hajcak
Journal:  Genes Brain Behav       Date:  2012-06-28       Impact factor: 3.449

2.  A neurotransmitter transporter encoded by the Drosophila inebriated gene.

Authors:  H Soehnge; X Huang; M Becker; P Whitley; D Conover; M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

3.  Characterization of the human dopamine transporter heterologously expressed in BHK-21 cells.

Authors:  T Lenhard; K Marheineke; B Lingen; W Haase; R Hammermann; H Michel; H Reiländer
Journal:  Cell Mol Neurobiol       Date:  1998-06       Impact factor: 5.046

4.  Neuroleptics and dopamine transporters.

Authors:  T A Reader; A R Ase; N Huang; C Hébert; N M van Gelder
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

6.  Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.

Authors:  T J Counihan; J B Penney
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

7.  Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster.

Authors:  L L Demchyshyn; Z B Pristupa; K S Sugamori; E L Barker; R D Blakely; W J Wolfgang; M A Forte; H B Niznik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Dopamine transporter genetic variants and pesticides in Parkinson's disease.

Authors:  Beate R Ritz; Angelika D Manthripragada; Sadie Costello; Sarah J Lincoln; Matthew J Farrer; Myles Cockburn; Jeff Bronstein
Journal:  Environ Health Perspect       Date:  2009-02-22       Impact factor: 9.031

9.  Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity.

Authors:  Elena Shumay; Joanna S Fowler; Nora D Volkow
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

10.  Functional analysis of upstream common polymorphisms of the dopamine transporter gene.

Authors:  Mikhil N Bamne; Michael E Talkowski; Kodavali V Chowdari; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-09       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.